Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Carisma Therapeutics Inc (CARM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Carisma Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.630 0.000    0.00%
01/05 - Closed. Currency in USD ( Disclaimer )
After Hours
1.630
0.000
0.000%
23:25:03 - Real-time Data
  • Volume: 96,908
  • Bid/Ask: 1.630 / 1.680
  • Day's Range: 1.600 - 1.670
Type:  Equity
Market:  United States
Carisma Therapeutics 1.630 0.000 0.00%

Carisma Therapeutics Company Profile

 
Read the Carisma Therapeutics Inc company profile to learn more about the business and the management team. View Carisma Therapeutics Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Carisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company’s ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phase 1 clinical trial to treat solid tumors; CT-0525, a CAR-monocyte that is in Phase 1 clinical trial to treat solid tumors; and CT-1119, a mesothelin-targeted CAR-Monocyte that is in pre-clinical stage to treat patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. It is also developing in vivo CAR-M cell therapies in collaboration with Moderna Therapeutics to address multiple cancer targets; and multiple assets for the potential treatment of diseases beyond oncology, including fibrosis and other immunologic and inflammatory diseases. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.

Contact Information

Address 3675 Market Street Suite 200
Philadelphia, 19104
United States
Phone 267-491-6422
Fax -

Top Executives

Name Age Since Title
Steven Kelly 58 2023 President, CEO & Director
Sanford S. Zweifach 67 2023 Independent Chairman of the Board
Regina Hodits 55 2023 Independent Director
Nina Bhardwaj - 2020 Member of Scientific Advisory Board
Briggs W. Morrison 64 2023 Independent Director
Padmanee Sharma - 2023 Member of Scientific Advisory Board
Carl H. June 70 - Member of Scientific Advisory Board
Lisa M. Coussens - - Member of Scientific Advisory Board
Saar Gill - - Co-Founder & Chairman of Scientific Advisory Board
Prasad S. Adusumilli - 2020 Member of Scientific Advisory Board
Michael Patrick Torok 45 2023 Independent Director
Björn Odlander 66 2023 Independent Director
Hyam I. Levitsky 66 - Member of Scientific Advisory Board
Lin Guey - 2023 Member of Scientific Advisory Board
John A. Hohneker 64 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CARM Price Commentary

Write your thoughts about Carisma Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Azizul Ariffin
Azizul Ariffin Dec 09, 2021 3:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is the outcome of the Type A Meeting?
Azizul Ariffin
Azizul Ariffin Dec 09, 2021 3:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is the outcome of the Type A Meeting?
Francis Dagostino
Francis Dagostino Oct 15, 2021 15:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i`m keeping it. i can`t say why, but i believe in this company. this is gonna be big company in the future. I feel it.
Nisar VM
Nisar VM Feb 08, 2021 17:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone here for long term ?
Cbpnana tititu
Cbpnana tititu Feb 08, 2021 17:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email